A number of psychostimulant-like cathinone compounds are being sold as 'legal' alternatives to methamphetamine or cocaine. The purpose of these experiments was to determine whether cathinone compounds stimulate motor activity and have discriminative stimulus effects similar to those of cocaine and/or methamphetamine. 3,4-Methylenedioxypyrovalerone (MDPV), methylone, mephedrone, naphyrone, flephedrone, and butylone were tested for locomotor stimulant effects in mice and subsequently for substitution in rats trained to discriminate cocaine (10 mg/kg, intraperitoneally) or methamphetamine (1 mg/kg, intraperitoneally) from saline. All compounds fully substituted for the discriminative stimulus effects of cocaine and methamphetamine. Several commonly marketed cathinones produce discriminative stimulus effects comparable with those of cocaine and methamphetamine, which suggests that these compounds are likely to have similar abuse liabilities. MDPV and naphyrone produced locomotor stimulant effects that lasted much longer than those of cocaine or methamphetamine and therefore may be of particular concern, particularly because MDPV is one of the most commonly found substances associated with emergency room visits because of adverse effects of taking 'bath salts'.
Introduction
Cathinones are a class of compounds derived from the active compound in khat, a mild stimulant widely used in the Middle East. The compounds have chemical structures similar to those of the amphetamines and thus may potentially share the psychostimulant effects of the amphetamines. There has been increasing use of synthetic cathinones quasilegally marketed as 'plant food' or 'bath salts' in Europe and the USA (NDIC, 2011) . In 2011, the Drug Enforcement Agency (DEA) identified a group of cathinones of 'great concern' for which they requested information, and temporary scheduling was obtained for three compounds identified as being of most concern: 3,4-methylenedioxypyrovalerone (MDPV), methylone, and mephedrone (DEA, 2011) .
The molecular activity of these compounds is similar to those of other psychostimulants. Mephedrone, butylone, naphyrone, and methylone inhibited serotonin transporters (SERTs) and dopamine transporters (DATs) and reduced uptake of serotonin and dopamine (Cozzi et al., 1999; Meltzer et al., 2006; Hadlock et al., 2011; López-Arnau et al., 2012; Martínez-Clemente et al., 2012) . One report indicated that all three compounds also inhibited the vesicular monoamine transporter 2 (VMAT-2) (López-Arnau et al., 2012) , but another study reported only weak inhibition of VMAT by methylone (Cozzi et al., 1999) . Mephedrone and methylone increased the release of dopamine, norepinephrine, and serotonin (Nagai et al., 2007; Kehr et al., 2011; Baumann et al., 2012) , although repeated dosing produced depletions of serotonin in the cortex and striatum similar to those produced by MDMA (Nagai et al., 2007; Hadlock et al., 2011; Baumann et al., 2012) . Taken together, these findings suggest that these compounds may produce behavioral effects similar to those produced by abused psychostimulants.
Unfortunately, there is a paucity of behavioral studies on many of these molecules. Among these molecules, mephedrone has been more thoroughly studied. Mephedrone increased locomotor activity (Nagai et al., 2007; Kehr et al., 2011; Baumann et al., 2012; Lisek et al., 2012; López-Arnau et al., 2012; Motbey et al., 2012) and wheel running (Huang et al., 2012) . Mephedrone also induced conditioned place preference (Lisek et al., 2012) and maintained selfadministration (Hadlock et al., 2011) . These results are quite similar to those obtained with known psychostimulants; however, mephedrone decreased social interaction (Motbey et al., 2012) .
Of the other cathinones that have been assessed, methylone and butylone also increased locomotor activity, which was blocked by various dopaminergic antagonists, as were the locomotor stimulant effects of mephedrone (Baumann et al., 2012; Lisek et al., 2012; López-Arnau et al., 2012) . MDPV also increased wheel running (Huang et al., 2012) . Only methylone has been assessed for drug discrimination. It fully substituted for the discriminative stimulus effects of amphetamine and MDMA, but not of DOM, a serotonergic hallucinogen (Dal Cason et al., 1997) .
The purpose of the present study was to characterize the potential abuse liability of several cathinone compounds identified by the DEA as being of particular concern (DEA, 2011). Abuse liability testing involves assessing the subjective and reinforcing effects of drugs; that is, do potential drugs of abuse produce discriminative and/or reinforcing stimulus effects similar to those of known drugs of abuse? The drug discrimination assay is a useful animal model for studying the perceptions of drug effects (Balster, 1991) . Another approach is to examine other features/aspects of potential drugs of abuse and compare them with those of known drugs of abuse. For example, abused psychostimulants, such as cocaine and methamphetamine, are named in such a manner because they produce characteristic increases in excitation and locomotor activity. Of course, not all compounds that increase motor activity are abused; however, screening for increased locomotor activity is 'permissive', in that all cocaine/amphetamine-like compounds do increase locomotor activity; hence, a compound that fails to alter locomotor activity has a much lower likelihood of being an abused substance.
Initially, to understand better the active time course and dose ranges of these compounds, 8-h tests for locomotor stimulant effects were conducted using multiple doses. The discriminative stimulus effects of these cathinones were then tested in rats trained to discriminate cocaine or methamphetamine from saline.
Methods

Subjects
Male Swiss Webster mice were obtained from Harlan (Indianapolis, Indiana, USA) at B8 weeks of age and tested at B10 weeks of age. Mice were group housed in cages on a 12 : 12-h light/dark cycle and were allowed free access to food and water. Male Sprague-Dawley rats were obtained from Harlan Sprague-Dawley (Indianapolis, Indiana, USA). All rats were housed individually and were maintained on a 12 : 12-h light/dark cycle (lights on at 07:00 h). Body weights were maintained at 320-350 g by limiting food to 15 g/day, which included the food received during operant sessions. Water was freely available. All housing and procedures were in accordance with the Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research (National Research Council, 2003) and were approved by the University of North Texas Health Science Center Animal Care and Use Committee.
Locomotor activity
The study was conducted using 40 Digiscan (model RXYZCM; Omnitech Electronics, Columbus, Ohio, USA) locomotor activity testing chambers (40.5 Â 40.5 Â 30.5 cm) housed within sound-attenuating chambers in sets of two. A panel of infrared beams (16 beams) and corresponding photodetectors were located in the horizontal direction along the sides of each activity chamber. A 7.5 W incandescent light above each chamber provided dim illumination, and fans provided an 80 dB ambient noise level within the chamber.
Separate groups of eight mice were injected with either vehicle (0.9% saline) or a test compound immediately before locomotor activity testing: methamphetamine (0.5, 1, 2, or 4 mg/kg); cocaine (5, 10, 20, or 40 mg/kg); methylone or butylone (1, 3, 10, or 30 mg/kg); MDPV, mephedrone, or flephedrone (0.3, 1, 3, 10, or 30 mg/kg); or naphyrone (3, 10, 30 or 100 mg/kg). In all studies, horizontal activity (interruption in photocell beams) was measured for 8 h within 10-min periods, beginning at 08:00 h (1 h after lights on). Behavioral observations on each mouse were recorded at 30, 120, and 480 min after administration of methylone, MDPV, mephedrone, butylone, and flephedrone (30 mg/kg) or naphyrone (100 mg/kg).
Discrimination procedures
Standard behavior-testing chambers (Coulbourn Instruments, Allentown, Pennsylvania, USA) were connected to IBM-PC compatible computers through LVB interfaces (Med Associates, East Fairfield, Vermont, USA). The computers were programmed in Med-PC for Windows, version IV (Med Associates) for the operation of the chambers and collection of data.
Using a two-lever choice methodology, a pool of rats previously trained to discriminate either methamphetamine (1 mg/kg) or cocaine (10 mg/kg) from saline, as described previously, (Gatch et al., 2011) were tested. Rats received an injection of either saline or drug and 10 min later were placed in the behavior-testing chambers, in which food (45 mg food pellets; Bio-Serve, Frenchtown, New Jersey) was available as a reinforcer for every 10 responses on a designated injection-appropriate lever. Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. The rats underwent B60 of these sessions before they were used in tests for substitution of the experimental compounds. Rats were used in testing once they had achieved nine of 10 sessions at 85% injection-appropriate responding for both the first reinforcer and the total session. The training sessions occurred on separate days in a double alternating manner (drug-drug-saline-salinedrug, etc.) until the training phase was complete, after which substitution tests were introduced into the training schedule such that at least one saline and one drug session occurred between each test (drug-salinetest-saline-drug-test-drug, etc.). The substitution tests were performed only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions.
Test sessions lasted for a maximum of 20 min. In contrast to training sessions, both levers were active, such that 10 consecutive responses on either lever led to reinforcement. Data were collected until the first reinforcer was obtained, or for a maximum of 20 min. Each compound was tested in groups of six rats. A repeated-measures design was used, such that each rat was tested at all doses of a given drug. Intraperitoneal injections of saline (1 ml/kg), methylone (0.5-5 mg/kg), mephedrone (0.5-5 mg/kg), MDPV (0.05-2.5 mg/kg), naphyrone (0.5-5 mg/kg), or butylone (0.5-10 mg/kg) were administered 15 min before the start of the test session. Flephedrone (0.5-10 mg/kg) was administered 60 min before the start of the test session. , and naphyrone (naphthylpyrovalerone hydrochloride) were provided by the National Institute on Drug Abuse Drug Supply Program. All drugs were dissolved in 0.9% saline and were administered intraperitoneally in a volume of 1 ml/kg. Dose increments were based on 1/3 logs.
Data analysis
Drug discrimination data are expressed as the mean percentage of drug-appropriate responses occurring in each test period. Rates of responding were expressed as a function of the number of responses made divided by the total session time. Graphs for percent drug-appropriate responding and response rate were plotted as a function of the dose of the test compound (log scale). Percent drug-appropriate responding was shown only if at least three rats completed the first fixed ratio. Full substitution was defined as greater than or equal to 80% drugappropriate responding, and was not significantly different from that of the training drug.
The potencies of methylone, mephedrone, MDPV, naphyrone, and butylone were calculated by fitting straight lines to the dose-response data for each compound using TableCurve 2D (Jandel Scientific, San Rafael, California, USA). Straight lines were fitted to the linear portion of dose-effect curves, including not more than one dose producing less than 20% of the maximal effect and not more than one dose producing greater than 80% of the maximal effect. Other doses were excluded from the analyses. Differences among ED 50 values were tested by one-way analysis of variance, followed by Tukey's test to compare individual means. Rates of responding were expressed as a function of the number of responses made divided by the total session time. Data on response rate data were analyzed by oneway repeated-measures analysis of variance. Effects of individual doses were compared with those of the vehicle control value using a-priori contrasts. The criterion for significance was set a priori at P less than 0.05.
Locomotor activity data were expressed as the mean number of photocell counts in the horizontal plane (ambulation counts) during each 10-min period of testing. A 30-min period, beginning when maximal stimulation of locomotor activity first appeared, as a function of dose, was used for analysis of dose-response data and for calculation of ED 50 values. TableCurve 2D was used to estimate the peak ambulation under each cathinone. The ED 50 values were then calculated by estimating the dose producing 50% of the peak ambulation from the ascending linear portion of the doseresponse curve. A two-way repeated-measures analysis of variance was carried out on horizontal activity counts/ 10-min interval. A one-way analysis of variance was carried out on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were made between each dose and the saline control using single degree of freedom F-tests.
Correlations between behavioral data and binding/functional data (Eshleman et al., 2013) were determined by least squares regression analysis using Excel 2007. ED 50 values for locomotor activity, substitution for cocaine or methamphetamine, and the cocaine/methamphetamine potency ratio from the present study were compared with receptor binding (K i ), IC 50 of the inhibition of neurotransmitter uptake, EC 50 of release of neurotransmitter, and percent maximum release for butylone, 4-FMC, MDPV, mephedrone, methylone, and naphyrone, at DAT, SERT, norepinephrine transporter (NET), and VMAT, as well as with binding to 5-HT1A, 5-HT2A, and 5-HT2C receptors (K i ), EC 50 and percent maximum stimulation of the 5-HT1A receptor, and IC 50 and percent maximum inhibition of 5-HT2A and 5-HT2C receptor signaling.
Results
Locomotor activity
Figures 1 and 2 show average horizontal activity counts/ 10 min as a function of time (0-8 h) and dose of each test compound. Figure 3 shows dose-effect curves for each compound at their time of peak effect, and Table 1 shows the ED 50 values. Each compound showed increases in locomotor activity as dose increased, up to a maximal effect, whereupon higher doses produced sharp decreases in locomotor activity. The two-way analysis of variance carried out on data for each compound yielded a significant main effect of treatment, as well as a significant treatment Â time period interaction (all P values < 0.01) 3,4-Methylenedioxypyrovalerone MDPV produced time-dependent and dose-dependent stimulation of locomotor activity at doses ranging from 0.3 Bath salt cathinones Gatch et al. 439 to 30 mg/kg (Fig. 1) . Stimulant effects of 1 and 3 mg/kg MDPV occurred within 10 min after injection and lasted for 190 min. Stimulant effects lasted 250 min after administration of 10 mg/kg MDPV, whereas after administration of 30 mg/kg MDPV, stimulant effects did not occur until 80 min after administration and lasted for 300 min. MDPV depressed locomotor activity between 10 and 50 min after injection at a dose of 30 mg/kg. During the 30-min time period, in which maximal stimulant effects first occurred (10-40 min after injection), significant stimulant effects (ED 50 of 1.26±0.08 mg/kg) occurred after administration of 1, 3, and 10 mg/kg (Fig. 3 ).
Mephedrone
Treatment with 3 and 10 mg/kg mephedrone resulted in stimulant effects that occurred within 10 min after Each column of five panels shows the data for the five doses tested. The gray bar shows the time range of peak effect. Data are from independent groups of eight mice per dose. *Stimulant effects (P < 0.05) versus vehicle control. wDepressant effects (P < 0.05) versus vehicle control. MDPV, 3,4-methylenedioxypyrovalerone.
Bath salt cathinones Gatch et al. 441
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. injection and lasted for 40-60 min (Fig. 1) . On the basis of the 30-min time period in which maximal stimulant effects first occurred (0-30 min after injection) significant effects (ED 50 of 1.38±1.22 mg/kg) were observed after administration of 3 and 10 mg/kg (Fig. 3 ).
Flephedrone
Treatment with 10 mg/kg flephedrone caused an initial depression of locomotor activity (between 10 and 30 min), followed by stimulation (Fig. 1) . The depressant effect of 10 mg/kg flephedrone occurred within 20 min after injection and lasted for 20 min. The stimulant effect occurred within 50 min after injection and lasted for 90 min. For the 30-min time period in which maximal stimulant effects first occurred (40-70 min after injection), significant stimulant effects (ED 50 = 2.04±0.35 mg/kg) occurred only after administration of 10 mg/kg (Fig. 3 ).
Methamphetamine
Treatment with 0.5 and 2 mg/kg methamphetamine resulted in stimulant effects that occurred within 10 min after injection and lasted for 140 to 210 min (Fig. 1) . Methamphetamine depressed locomotor activity between 30 and 60 min after administration of 4 mg/kg. Stimulant effects did not occur until 90 min after administration of 4 mg/kg and lasted for 270 min. For the 30-min time period in which maximal stimulant effects first occurred (20-50 min after injection), significant stimulant effects (ED 50 = 0.30±0.40 mg/kg) occurred after administration of 0.5 and 2 mg/kg (Fig. 3) .
Naphyrone
Naphyrone caused a time-dependent and dose-dependent stimulation of locomotor activity at doses ranging from 10 to 100 mg/kg (Fig. 2) . Stimulant effects of 10 and 30 mg/kg naphyrone occurred within 10 min after injection and lasted for 110-280 min. Naphyrone depressed locomotor activity between 10 and 50 min after injection of 100 mg/kg. Stimulant effects of 100 mg/kg did not occur until 80 min after administration and lasted for up to 8 h. On the basis of the 30-min time period in which maximal stimulant effects occurred (0-30 min after injection), significant effects (ED 50 = 8.91±0.09 mg/kg) were observed after administration of 10 and 30 mg/kg (Fig. 3 ).
Methylone
Treatment with methylone resulted in time-dependent and dose-dependent stimulation of locomotor activity at doses ranging from 3 to 30 mg/kg (Fig. 2) . Stimulant effects of 3 and 10 mg/kg methylone occurred within 10 min after injection and lasted for 60 to 120 min. Stimulant effects of 30 mg/kg methylone fluctuated during the first 30 min (but were significantly different from those of vehicle control) and lasted for 180 min. Significant stimulant effects during the time in which maximal stimulant effects first occurred (0-30 min following injection) were observed after administration of 3, 10, and 30 mg/kg (Fig. 3) , and an ED 50 of 1.48±0.07 mg/kg was calculated.
Butylone
Butylone produced time-dependent and dose-dependent stimulation of locomotor activity at doses ranging from 10 to 30 mg/kg (Fig. 2) . Stimulant effects of 10 mg/kg butylone occurred within 10 min after injection and lasted for 130 min. Stimulant effects of 30 mg/kg butylone fluctuated during the first 30 min (but were not significantly different from those of vehicle control) and lasted for 190 min. On the basis of the 30-min time period in which maximal stimulant effects first occurred (0-30 min after injection), significant effects (ED 50 of 2.57±0.21 mg/kg) were observed after administration of 10 mg/kg (Fig. 3 ).
Cocaine
Treatment with cocaine resulted in time-dependent and dose-dependent stimulation of locomotor activity after administration at doses of 10-40 mg/kg (Fig. 2) . Stimulant effects of 10, 20, and 40 mg/kg occurred within 10 min after injection and lasted for 120-170 min. On the basis of the 30-min time period in which maximal stimulant effects occurred (0-30 min following injection), significant effects (ED 50 = 7.24±0.14 mg/kg) were observed after administration of 10, 20, and 40 mg/kg (Fig. 3) .
Discrimination
Cocaine-trained rats
Each of the cathinones fully substituted for the discriminative stimulus effects of cocaine (Fig. 4) . Bath salt cathinones Gatch et al. 443 ED 50 values differed across test drugs [F(5,30) = 97.00, P < 0.001] and are shown in Table 1 . The rank order of potency in cocaine-trained rats was MDPV Z methylone = mephedrone > naphyrone = flephedrone > butylone. None of the compounds produced a significant overall effect on response rate.
Methamphetamine-trained rats
Each of the cathinones also fully substituted for the discriminative stimulus effects of methamphetamine (Fig. 5) .
ED 50 values differed across test drugs [F(5,30) = 18.82, P < 0.001] and are shown in Table 1 . The rank order of potency in methamphetamine-trained rats was MDPV = mephedrone > butylone = methylone = flephedrone = naphyrone. Mephedrone decreased response rate at doses of 2.5 and 5 mg/kg, with the maximum effect (62% of vehicle control) after administration of 5 mg/kg [F(4,20) = 5.31, P = 0.004]. None of the other compounds produced a significant overall effect on the response rate.
Correlations
The potency of these cathinones to bind to VMAT-2 (r 2 = 0.86, P < 0.01) and inhibit the uptake of norepinephrine at VMAT-2 (r 2 = 0.72, P < 0.05) as observed in a recent study (Eshleman et al., 2013) correlated with their potency to stimulate locomotor activity in the present study. Binding or function (uptake inhibition or release) of DAT, NET, and SERT did not correlate with the potency to stimulate locomotor activity. Binding to or activation of 5-HT1A, 5-HT2A, or 5-HT2C receptors also failed to correlate with the potency to stimulate locomotor activity.
Differences in the potency of the cathinones to substitute for cocaine in the present study were predicted by their potency to activate 5-HT1A signaling in the study by Eshleman et al. (2013) (r 2 = 0.7, P < 0.05); similarly, differences in the potency of the cathinones to substitute for methamphetamine were predicted by the efficacy of release of norepinephrine at VMAT-2 (r 2 = 0.76, Flephedrone Cocaine Vehicle control P < 0.025). Further, in the present study, the potency of the cathinones to substitute for cocaine did not correlate well with their potency to substitute for methamphetamine (r 2 = 0.45, NS). However, the ratio of the potencies for substitution of methamphetamine and cocaine by the cathinones correlated with their potency to activating 5-HT1A signaling in the study by Eshleman et al. (2013) (r 2 = 0.66, P < 0.05). Binding to or function (uptake inhibition or release) of DAT, NET, and SERT did not correlate with the potency to substitute for cocaine or methamphetamine or with the cocaine/methamphetamine potency ratio. Binding to or activation of 5-HT2A or 5-HT2C receptors also failed to correlate with the potency in the discriminative stimulus assay.
Discussion
In the present study, a group of synthetic cathinones (methylone, mephedrone, MDPV, naphyrone, flephedrone, and butylone) flagged for study by the DEA all produced locomotor stimulant effects similar to those of methamphetamine and discriminative stimulus effects similar to those of both cocaine and methamphetamine. These findings agree with earlier findings according to which methylone, mephedrone, MDPV, and butylone increased locomotor activity (Baumann et al., 2012; Huang et al., 2012; Lisek et al., 2012; López-Arnau et al., 2012) and methylone fully substituted for the discriminative stimulus effects of the psychostimulant amphetamine (Dal Cason et al., 1997) . Taken together, these findings suggest that these compounds produce behavioral effects similar to those of cocaine and methamphetamine and that they may share the abuse liability of these two abused psychostimulants.
These findings are in agreement with those of earlier studies that concluded that the pharmacological activity of these compounds is similar to that of other psychostimulants, such as blockade of monoaminergic transporters and/or increased release of monoamines (Cozzi et al., Substitution for the discriminative stimulus effects of methamphetamine. Upper panels: percentage of total responses made on the drug-appropriate lever. Lower panels: rate of responding in responses per second (responses/s). All of the cathinones fully substituted for the discriminative stimulus effects of methamphetamine (> 80% drug-appropriate responding). n = 6. Ctrl, control; MDPV, 3,4-methylenedioxypyrovalerone.
1999; Meltzer et al., 2006; Nagai et al., 2007; Baumann et al. 2012) . In addition, a recent study thoroughly characterized the receptor mechanisms of each of the six cathinone compounds tested in the present study (Eshleman et al., 2013) . MDPV, butylone, and naphyrone were monoamine uptake inhibitors (similar to cocaine), whereas methylone, mephedrone, and flephedrone were monoamine releasers (similar to methamphetamine). The cathinone compounds had no direct dopamine receptor effects and only weak effects at VMAT-2; however, they did have some serotonin receptor effects: they were agonists at 5-HT1A and antagonists at 5-HT2A and 5-HT2C receptors (Eshleman et al., 2013) .
In the present study, differences in potency among the cathinones in producing locomotor stimulant effects or in substitution for methamphetamine were predicted by their potency in producing effects on VMAT in the study by Eshleman et al. (2013) . Differences in the potency of substitution for cocaine and the cocaine/methamphetamine potency ratio were predicted by potency to activate 5-HT1A receptors. However, the potency or efficacy of monoamine activity did not predict differences in potency of the cathinones to produce behavioral effects in the present study. It should be noted that these correlations predict differences in potencies of the various cathinones. Changes in monoamine levels through release or uptake at the membrane transporters are likely important mechanisms for the behavioral effects of these cathinones, as for other psychostimulants. It is likely that reaching a threshold level of release or uptake is sufficient to produce the behavioral effects; subtle differences do not seem to be important. In contrast, the activity of the 5-HT1A receptor and VMAT-2 may contribute to individual differences in potency of these cathinones. Confirmation of these putative roles will require direct antagonism studies on the behavioral effects, and their generality across cathinones will require further study. Different species were used for the locomotor activity (mice) and discrimination assays (rats), on the basis of the ease of use and the availability of existing literature. Despite the physiological differences between the species, the murine locomotor activity data have been excellent at predicting dose ranges and pretreatment times for rat drug discrimination. In the present study, the locomotor activity assay was a good predictor for dose range in the drug discrimination assay, although naphyrone was less potent in stimulating locomotor activity than in producing cocaine-like and methamphetamine-like discriminative stimulus effects. However, the magnitude of the locomotor stimulant effect does not seem to be a good predictor of abuse liability, as mephedrone produced relatively modest increases in the locomotor activity, yet produced full substitution for both cocaine and methamphetamine, and also induced a conditioned place preference (Lisek et al., 2012) and maintained selfadministration (Hadlock et al., 2011) .
What may be of more interest in the present data set is the duration of the locomotor stimulant effects. The present study tested extended (8 h) time courses of a full dose range of these compounds. Acute increases in psychostimulant effects were observed, as noted in the earlier studies; however, large doses of some compounds had very long acting effects, and dose-effect functions for all compounds were biphasic, showing a descending limb at high doses. MDPV, similar to methamphetamine, produced long-lasting stimulant effects that lasted for 5-6 h. The highest dose of naphyrone (100 mg/kg) did not produce stimulant effects for 2 h, but the effects lasted until nearly 8 h after administration. In fact, MDPV and naphyrone both produced depressant effects for nearly an hour after administration. The other compounds produced a similar pattern, although the degree of depression was not so large, and the extension of the time course of stimulation was not nearly as large as that for MDPV, naphyrone, and methamphetamine.
There have been anecdotal reports in the news media on extremely long-lasting and unpleasant effects of some of these compounds. Unfortunately, it is impossible to determine exactly which compounds illicit users have taken; however, MDPV is one of the most commonly found compounds in samples of 'bath salts' (Spiller et al., 2011) . The long time course of MDPV combined with the substantial depressant effects may account for the frequency of emergency room visits by users of MDPVcontaining 'bath salts'.
The present findings indicate that these six synthetic cathinones produce locomotor stimulant and discriminative stimulus effects similar to those of abused psychostimulants. Further, the long time courses of MDPV and naphyrone suggest that uncontrolled use of these compounds may be hazardous. Initial conditioned place preference studies conducted in our laboratory suggest that these cathinones can produce reward-like stimuli (unpublished data), and other studies have reported that mephedrone produced a conditioned place preference (Lisek et al., 2012) and maintained self-administration (Hadlock et al., 2011) . Confirmation that animals will self-administer the remainder of these compounds is essential, but taken together, these data suggest that these compounds have abuse liability similar to that of cocaine and methamphetamine and should be controlled to a similar degree.
